GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Premier Health Of America Inc (TSXV:PHA) » Definitions » Research & Development

Premier Health Of America (TSXV:PHA) Research & Development : C$0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Premier Health Of America Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Premier Health Of America's Research & Development for the three months ended in Dec. 2024 was C$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.0 Mil.


Premier Health Of America Research & Development Historical Data

The historical data trend for Premier Health Of America's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Premier Health Of America Research & Development Chart

Premier Health Of America Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Research & Development
Get a 7-Day Free Trial - - - - -

Premier Health Of America Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Premier Health Of America Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Premier Health Of America  (TSXV:PHA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Premier Health Of America Research & Development Related Terms

Thank you for viewing the detailed overview of Premier Health Of America's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Premier Health Of America Business Description

Traded in Other Exchanges
N/A
Address
1114 boul. Cure-Labelle, Suite 1, Blainville, QC, CAN, J7C 2M9
Premier Health Of America Inc is a Canadian Healthtech company that provides a comprehensive range of staffing and outsourced services solutions for healthcare needs to governments, corporations, and individuals. It uses its proprietary platform for the healthcare services sector digital transformation to provide patients with faster, cheaper, and more accessible care services. The Company has two operating segments: the Per Diem segment and the Travel Nurse segment. The majority of its revenue comes from the Travel Nurse segment, which includes the Canadian Health Care Agency, Solution Staffing, Premier Health Nordik, and Solutions Nursing, four subsidiaries that offer their respective services to the federal and provincial governments for nursing and assistance, mostly in remote regions.
Executives
Guy D'aoust Senior Officer
Hubert Marleau Director
Simon Belval Senior Officer
Jean-robert Pronovost Director, Senior Officer
Eric Chouinard Director
Sylvain Charbonneau Senior Officer
Joseph Cianci Director, Senior Officer
Martin Legault 10% Security Holder, Director, Senior Officer
Marie Laberge Director